Price: $112.50 per injection
Have you tried every fad diet and "hottest" new weight loss supplement out there, and are still struggling to maintain a healthy weight? Do you suffer from weight-related conditions such as hypertension or type II diabetes? Weekly injections of WEGOVY™ semaglutide sodium might be the long-term solution you've been waiting for.
Benefits of WEGOVY™ semaglutide sodium injections, when used alongside a reduced-calorie diet and increased physical activity include:
- Can be used long-term as a weight loss medication
- Decreases food intake
- Blood sugar-lowering effects
- Suppresses appetite & hunger cravings
- Reduces fat mass in the body
WEGOVY™ (semaglutide sodium) is an FDA-approved injectable drug for chronic weight management, especially effective in adults with a BMI over 30 and/or weight-related conditions such as hypertension or type II diabetes.
Spruce is thrilled to offer WEGOVY™ as a promising long-term weight loss treatment. Current studies suggest that most people that use Semaglutide sodium for weight loss are able to lose at least 5% of their body weight within 12 weeks of taking the treatment (not including the titration period).
How it Works
Technically, semaglutide functions by mimicking glucagon-like peptide-1 (GLP-1), a hormone the body naturally produces. GLP-1 is normally secreted in the gut when we eat fats and carbohydrates. When this hormone is released, it targets various receptors in the body to help stimulate insulin release, while also suppressing glucagon, slowing gastric emptying, and increasing feelings of fullness. GLP-1 receptor agonists were initially developed to help patients with type 2 diabetes, but it was later proven that the hormone mimicker also helps obese patients.
In basic terms, the actions this hormone takes when released, as described above, all add up to signal to the brain that we feel full and content after eating. With the steady supply of this hormone that semaglutide provides, obese patients are finally able to receive the bodily signals telling them they are full after eating much smaller portions.
Not all patients qualify for treatment. A history prior to treatment is required to rule out other medical illnesses/diagnosis.
Schedule your WEGOVY™ semaglutide sodium consultation today to determine whether breakthrough weight loss treatment could be right for you!
The most common adverse reactions, reported in greater than or equal to 5% of patients treated with WEGOVY™ are: nausea, diarrhea, vomiting, constipation, abdominal pain, headache, fatigue, dyspepsia, dizziness, abdominal distension, eructation, hypoglycemia in patients with type 2 diabetes, flatulence, gastroenteritis, and gastroesophageal reflux disease.